Retrokor Indications/Uses

Susceptible organisms: Staphylococcus aureus (including penicillinase-producing strains), Staphylococcus epidermidis, Pneumococcus, group A streptococcus, group B streptococcus (Streptococcus agalactiae), Streptococcus viridans, Streptococcus bovis, Aeromonas spp., Alcaligenes spp., Branhamella catarrhalis, Citrobacter spp., Enterobacter spp (some strains are resistant), Escherichia coli, Haemophilus ducreyi, Haemophilus influenzae (including ampicillin-resistant strains), Haemophilus parainfluenzae, Klebsiella spp. (Klebsiella pneumoniae), Moraxella, Proteus morganii, Proteus mirabilis, Proteus vulgaris, Providencia, Neisseria gonorrhoeae (including penicillinase-producing strains), Neisseria meningitidis, Plesimonas shigelloides, Pseudomonas aeruginosa (some strains are resistant), Salmonella spp. (including Salmonella typhi), Serratia spp. (including S. marcescens), Shigella spp., Yersinia spp. (including Y. enterocolitica), Treponema pallidum, Bacteroides spp. (including some strains of Bacteroides fragilis), Clostridium spp. (except Clostridium difficile), Fusobacterium spp. (except F. Mortiferum, F. Varium), Peptococcus spp., Peptostreptococcus spp.
Ceftriaxone is indicated for the treatment of the following infections caused by susceptible microorganisms:
Respiratory infections eg, pneumonia, bronchitis.
Otorhinolaryngology infections, renal or urinary tract infections, meningitidis, perioperative prophylaxis of infections, infections of bone and joint; skin, wound and soft tissue; peritonitis, cholecystitis, cholangitis, gastrointestinal tract, genital infections eg, gonorrhea.
Also for the treatment of infections in patients with decline of immunologic function.